Skip to content
Adline Chem Lab logo

Adline Chem Lab

524604 BSE
Price unavailable

Adline Chem Lab (ADLINE) share price was ₹15.79 at the 12 Oct 2026 close; sector Healthcare. The share price fell 2.6% over the year to 12 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue was under ₹1 Cr in both quarters and net profit was ₹0.04 Cr, against −₹0.05 Cr a year earlier (compared with Jun 2025). Promoters held 25.85% of Adline Chem Lab in Sep 2026, unchanged from Jun 2026.

Close 12 Oct 2026 ₹15.79 +0.90 +6.04% 1Y

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
EBITDA
−₹20.00 L
Return on Equity
15.84%
Debt to Equity
0
Book Value
−₹3.03
EPS (TTM)
−₹0.30

Price-based figures · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,766.5035.044,23,843 Cr5.070.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,635.0087.452,55,779 Cr15.260.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,598.4072.191,74,908 Cr9.520.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,184.70107.941,18,042 Cr22.270.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,180.5026.271,17,755 Cr4.340.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,341.0034.731,11,931 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,370.5032.831,10,717 Cr3.130.96%11.21%14.88%28,589 Cr3,356 Cr
Adline Chem Lab (this company)
——9 Cr—0.00%15.84%-393.80%0 Cr-0 Cr
Median 8 companies₹1,766.5035.041,17,899 Cr5.070.47%14.56%16.41%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Weaknesses

2
  • Company has low interest coverage ratio.
  • Promoter holding is low: 25.8%

Technical Indicators

Oscillators

Bearish

Bearish
4
Neutral
3
Bullish
2

Overall

Bullish

Bearish
4
Neutral
3
Bullish
12

Moving Averages

Bullish

Bearish
0
Neutral
0
Bullish
10

Growth Rate

Revenue Growth
-100%

change over 1 year

Net Income Growth
200% higher than 3Y

change over 1 year

Cash Flow Change
30.43%

change over 1 year

EBITDA Margin Change
—

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0
0
0
0
0
0
0
0
0
0
0
0
0
Expenses
0.08
0.03
0
0.07
0.1
0.07
0.1
0.06
0.03
0.05
0.03
0.08
0.04
Operating Profit
-0.08
-0.03
0
-0.07
-0.1
-0.07
-0.1
-0.06
-0.03
-0.05
-0.03
-0.08
-0.04
Other Income
0
0
0
0.03
0
0
0
0.25
0
0
0
0.01
0.12
Interest
0
0.03
0.03
0
0.03
0.03
0.03
0.03
0.03
0.03
0.04
0.04
0.05
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
-0.08
-0.06
-0.03
-0.04
-0.13
-0.1
-0.13
0.16
-0.06
-0.08
-0.07
-0.11
0.03
Tax %
0%
-16.67%
-33.33%
0%
-7.69%
-10%
-7.69%
-31.25%
-16.67%
-12.5%
-14.29%
-9.09%
-33.33%
Net Profit
-0.08
-0.05
-0.02
-0.04
-0.13
-0.09
-0.12
0.21
-0.05
-0.07
-0.06
-0.09
0.04
EPS (₹)
-0.14
-0.09
-0.03
-0.07
-0.22
-0.15
-0.21
0.36
-0.09
-0.12
-0.1
-0.15
0.07
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
15.36
16.94
17.18
8.1
5.59
6.59
6.33
0.74
0
0
0
0
0
Expenses
14.42
16.5
15.97
7.23
5.01
9.91
6.56
1.04
0.8
0.18
0.3
0.2
0.2
Operating Profit
0.94
0.44
1.21
0.87
0.58
-3.32
-0.23
-0.3
-0.8
-0.18
-0.3
-0.2
-0.2
OPM %
6.12%
2.6%
7.04%
10.74%
10.38%
-50.38%
-3.63%
-40.54%
—
—
—
—
—
Other Income
0.08
0.1
0.08
0.21
0.25
0.26
0
1.33
-3.35
0
0.25
0.01
0.13
Interest
0.48
0.44
0.32
0.34
0.07
0.02
0.03
0.01
0
0.12
0.16
0.13
0.16
Depreciation
0.51
0.09
0.96
0.73
0.73
0.42
1.02
0.35
0.09
0
0
0
0
PBT
0.03
0.01
0.01
0.01
0.03
-3.5
-1.28
0.67
-4.24
-0.3
-0.21
-0.32
-0.23
Tax %
33.33%
100%
0%
100%
0%
7.43%
0%
-7.46%
0%
-10%
-33.33%
-12.5%
—
Net Profit
0.02
0.01
0.01
0
0.03
-3.76
-1.28
0.72
-4.23
-0.27
-0.13
-0.28
-0.18
EPS (₹)
0.03
0.02
0.02
0
0.05
-6.43
-2.19
1.23
-7.23
-0.46
-0.22
-0.48
-0.3
Div. Payout %
0%
0%
0%
—
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
5.85
5.85
5.85
5.85
5.85
5.85
5.85
5.85
5.85
5.85
5.85
5.85
Reserves
1.21
1.21
1.19
1.18
1.18
-2.64
-3.92
-3.2
-7.42
-7.22
-7.34
-7.62
Borrowings
9.25
9.01
9.94
11.32
5.35
2.85
2.5
1.32
1.33
1.36
1.49
1.8
Other Liabilities
2.32
2.34
3.97
5.01
9.46
1.52
1.2
0.91
0.31
0.06
0.08
0.04
Total Liabilities
18.63
18.41
20.95
23.36
21.84
7.58
5.63
4.88
0.07
0.05
0.08
0.07
Fixed Assets
10.08
10.27
12.68
12.45
11.99
4.78
3.64
4.43
0
0
0
0
CWIP
0.2
0.2
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
8.35
7.94
8.27
10.91
9.85
2.8
1.99
0.45
0.07
0.05
0.08
0.07
Total Assets
18.63
18.41
20.95
23.36
21.84
7.58
5.63
4.88
0.07
0.05
0.08
0.07
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.39
0.83
2.46
0.89
-0.95
-11.34
-0.29
0.21
0.01
-0.17
-0.23
-0.16
Investing
-2.44
-0.21
-3.18
-0.37
-0.28
11.24
0.12
0
0
0
0
0
Financing
2.18
-0.78
0.63
1.04
-0.29
-0.02
-0.03
-0.01
0
0.15
0.25
0.16
Net Cash Flow
0.12
-0.15
-0.09
1.56
-1.51
-0.12
-0.21
0.2
0.01
-0.02
0.02
0
Free Cash Flow
-2.06
0.62
-0.73
0.36
-1.23
-0.1
-0.17
0.21
0.01
-0.17
-0.23
-0.16
CFO/OP
41
189
203
102
-164
342
126
-70
-1
94
110
80
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
57.74
53.87
56.3
103
136
79.2
91.11
34.53
—
—
—
—
Inventory Days
77.67
46.15
55.54
181
833
81.53
46.98
198
—
—
—
—
Days Payable
43.12
41.39
49.24
63.34
437
41.89
28.91
342
—
—
—
—
Cash Conversion Cycle
92.3
58.62
62.6
221
532
119
109
-110
—
—
—
—
Working Capital Days
24.71
-6.46
-29.53
-140
-318
-72
-66.89
-765
—
—
—
—
ROCE %
3.39%
2.84%
2%
1.98%
0.59%
-40.35%
-23.83%
-10.95%
5.9%
—
—
-1266.67%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Adline Chem Lab insights

61 extracted metrics + investor summaries across FY09–FY27.

Shareholding Pattern

Public63.71%Others10.43%Promot.25.85%As ofSep 2026

Documents

Frequently Asked Questions about Adline Chem Lab

What does Adline Chem Lab Ltd do?
Incorporated in 1988, Adline Chem Lab Ltd trades in pharmaceutical formulations, Nutraceutical, and Dietary products.[1]
Where is Adline Chem Lab Ltd (ADLINE) listed?
Adline Chem Lab Ltd trades under code 524604 on the BSE.
Which sector does Adline Chem Lab Ltd belong to?
Adline Chem Lab Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the Return on Equity (ROE) of Adline Chem Lab Ltd?
Adline Chem Lab Ltd reported a return on equity of 15.84%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1988, Adline Chem Lab Ltd trades in pharmaceutical formulations, Nutraceutical, and Dietary products.[1]

Website kamronlabs.com
Face Value ₹ 10
Shares Outstanding 58,26,472

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524604.md for Adline Chem Lab Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month